Find a trial

ARTEMIDE-Lung02 / D702BC00001

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Locations Townsville, Southport

Diagnosis Lung cancer

ARTEMIDE-Lung03 / D702FC00001

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Non-squamous NSCLC

Locations Townsville, Southport

Diagnosis Lung cancer

ELEGANT / STML-ELA-0422

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Locations Southport, Wesley, Townsville, Hobart, Adelaide

Diagnosis Breast cancer

VIKTORIA-1 / CELC-G-301

Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/​HER2- Breast Cancer

Locations Southport

Diagnosis Breast cancer

XPORT-EC-042

Selinexor in Maintenance Therapy After Systemic Therapy for Participants with P53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma

Locations Southport

Diagnosis Endometrial cancer

X4P-001-110

A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/​or Serious Infections

Locations Southport

Diagnosis Neutropenic disorders